Algorithms in allergy: Management of allergic reactions to COVID-19 vaccines.
作者信息
Johnson Mary, Kline Olivia, Torres Jaen Maria Jose, Nadeau Kari C
机构信息
Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma Andalusian Centre for Nanomedicine and Biotechnology (BIONAND), Málaga, Spain.
出版信息
Allergy. 2025 Feb;80(2):638-640. doi: 10.1111/all.16358. Epub 2024 Oct 30.
Abstract
摘要
相似文献
1
Algorithms in allergy: Management of allergic reactions to COVID-19 vaccines.过敏症中的算法：新冠疫苗过敏反应的管理
Allergy. 2025 Feb;80(2):638-640. doi: 10.1111/all.16358. Epub 2024 Oct 30.
2
Allergic reactions against Covıd-19 vaccines.对新冠病毒疫苗的过敏反应。
Turk J Med Sci. 2021 Oct 21;51(5):2233-2242. doi: 10.3906/sag-2104-329.
3
Challenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar.聚乙二醇和聚山梨醇酯80过敏诊断中的挑战：对COVID-19 mRNA疫苗接种计划中过敏反应的影响：来自卡塔尔的经验
Front Allergy. 2025 Jan 7;5:1502285. doi: 10.3389/falgy.2024.1502285. eCollection 2024.
4
Analysis of Allergy and Hypersensitivity Reactions to COVID-19 Vaccines According to the EudraVigilance Database.根据欧洲药品不良反应数据库对新冠疫苗过敏及超敏反应的分析
Life (Basel). 2024 May 31;14(6):715. doi: 10.3390/life14060715.
5
Patients with suspected allergic reactions to COVID-19 vaccines can be safely revaccinated after diagnostic work-up.对新冠疫苗疑似过敏反应的患者在进行诊断检查后可安全地再次接种疫苗。
Clin Transl Allergy. 2021 Jul;11(5):e12044. doi: 10.1002/clt2.12044.
6
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.关于 COVID-19 疫苗过敏反应风险的更新指南以及建议的评估和管理：一个 GRADE 评估和国际共识方法。
J Allergy Clin Immunol. 2023 Aug;152(2):309-325. doi: 10.1016/j.jaci.2023.05.019. Epub 2023 Jun 7.
7
Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System.美国区域卫生系统中采用确证性检测评估对 mRNA COVID-19 疫苗的过敏和过敏反应。
JAMA Netw Open. 2021 Sep 1;4(9):e2125524. doi: 10.1001/jamanetworkopen.2021.25524.
8
Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations.当前可用的COVID-19疫苗的过敏反应：病理生理学、因果关系及治疗考量
Vaccines (Basel). 2021 Mar 5;9(3):221. doi: 10.3390/vaccines9030221.
9
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.欧洲过敏与临床免疫学会关于严重 COVID-19 疫苗过敏反应的诊断、管理和预防的声明
Allergy. 2021 Jun;76(6):1629-1639. doi: 10.1111/all.14739.
10
Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.自报高风险过敏史与 COVID-19 疫苗接种后过敏症状的关联。
JAMA Netw Open. 2021 Oct 1;4(10):e2131034. doi: 10.1001/jamanetworkopen.2021.31034.
本文引用的文献
1
Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines.在针对抗SARS-CoV-2 mRNA疫苗超敏反应的过敏风险评估背景下进行聚乙二醇和聚山梨酯80皮肤试验
Vaccines (Basel). 2023 Apr 28;11(5):915. doi: 10.3390/vaccines11050915.
2
The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey.聚乙二醇和聚山梨醇酯 80 皮肤试验在 COVID-19 疫苗接种运动中的作用：来自意大利多中心调查的结果。
Eur Ann Allergy Clin Immunol. 2024 Jan;56(1):17-25. doi: 10.23822/EurAnnACI.1764-1489.291. Epub 2023 Mar 16.
3
A Prospective Validation of a Diagnostic Algorithm for Hypersensitivity Reactions to COVID-19 Vaccines.新型冠状病毒肺炎疫苗超敏反应诊断算法的前瞻性验证
J Investig Allergol Clin Immunol. 2023 Oct 16;33(5):392-394. doi: 10.18176/jiaci.0877. Epub 2022 Dec 20.
4
What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later.我们从与严重急性呼吸综合征冠状病毒 2 型疫苗相关的变应原性和不良反应中学到了什么：一年后。
Ann Allergy Asthma Immunol. 2022 Jul;129(1):40-51. doi: 10.1016/j.anai.2022.03.030. Epub 2022 Apr 4.
5
Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper.过敏与 COVID-19 疫苗：ENDA/EAACI 立场文件。
Allergy. 2022 Aug;77(8):2292-2312. doi: 10.1111/all.15241. Epub 2022 Mar 5.
6
Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination-Associated Hypersensitivity Reactions.基于人群的急性发作 COVID-19 mRNA 疫苗接种相关过敏反应的发生率、严重程度及相关风险因素。
J Allergy Clin Immunol Pract. 2022 Mar;10(3):827-836. doi: 10.1016/j.jaip.2021.12.021. Epub 2021 Dec 29.
7
Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines.与 COVID-19 疫苗相关的过敏反应发生率与其他疫苗相当。
Vaccine. 2022 Jan 21;40(2):183-186. doi: 10.1016/j.vaccine.2021.11.066. Epub 2021 Nov 27.
8
Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.高过敏风险成年人接种辉瑞-BioNTech COVID-19 疫苗后的过敏反应发生率。
JAMA Netw Open. 2021 Aug 2;4(8):e2122255. doi: 10.1001/jamanetworkopen.2021.22255.
9
COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach.有过敏反应报告的患者的COVID-19疫苗接种：最新证据与建议方法
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2135-2138. doi: 10.1016/j.jaip.2021.03.053. Epub 2021 Apr 15.
10
Acute Allergic Reactions to mRNA COVID-19 Vaccines.mRNA COVID-19 疫苗的急性过敏反应。
JAMA. 2021 Apr 20;325(15):1562-1565. doi: 10.1001/jama.2021.3976.
Zotero 插件